Dr. Rupesh Kotecha is a renowned radiation oncologist in leadership roles at Miami Cancer Institute. He is an associate professor at Florida International University's college of medicine and an adjunct faculty member at Memorial Sloan Kettering.
Small cell mesothelioma is an extremely rare subtype of malignant mesothelioma. Although often mistaken for small cell lung cancer (SCLC), small cell mesothelioma forms on the lining of the lungs, while SCLC develops inside the lungs.
Small cell mesothelioma is a subtype of epithelial cell mesothelioma. However, many mesothelioma tumors with small cell features are biphasic, which means they contain a combination of epithelial and sarcomatoid cells.
This type of mesothelioma grows in a pattern like small cell carcinoma. However, the tumors do not display the stream, ribbon or rosette patterns in the subtype of lung carcinoma.
Small cell mesothelioma tumors grow in the peritoneum (abdominal lining), but they can also arise in the pleura (lung lining) or the pericardium (heart sac). Most of these tumors are not entirely composed of small cells. Instead, they often contain normal mesothelioma and other assorted neoplastic cells. For a tumor to qualify as this type, roughly half or more of all cells should display a small cell pattern.
Learn about your diagnosis, top doctors and how to pay for treatment in our free mesothelioma guide.
Get Your GuideDiagnosing this cell type is difficult because the cells look like other small cell neoplasms. Doctors must run immunohistochemical tests to differentiate between the diseases.
Conditions Similar to Small Cell Mesothelioma
A single biopsy may not always contain a representative sample of the cells in the entire tumor. In one study, small cells comprised 80% to 100% of the biopsy material. But only 15% to 20% of the whole tumor. Doctors may retrieve several samples to make an accurate mesothelioma diagnosis.
After immunohistochemical staining, the tumor cells will test positive for different compounds. This result helps the medical team narrow the diagnosis. Small cell mesothelioma and small cell carcinoma have similar-looking cells. However, each disease reacts to different chemical markers.
Diagnosing the right type is vital because different cancers respond to other treatments.
We make getting expert care from the nation’s top mesothelioma specialists easy.
Find My SpecialistDeveloping a standard of treatment for small cell mesothelioma is difficult. Because doctors have not reported many cases, they must rely on standard mesothelioma treatment approaches.
Small cell lung cancer (SCLC) is more aggressive than other types of lung cancer. It is unclear if the prognosis for small cell mesothelioma differs from other epithelial mesotheliomas.
In 2020, researchers said small cell mesothelioma has a similar cell morphology to SCLC but a different immunohistochemical profile. They concluded that the rare variant has a poor prognosis, with a mean survival of about 8 months.
Recommended ReadingStay up-to-date on treatment, research, clinical trials, doctors and survivors
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our privacy policy and terms of service for more information about our website.
This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome.
The Mesothelioma Center’s claim as the most trusted resource is based on our more than 150 5-star Google and BBB reviews. Our organization also helps more than half of all mesothelioma patients annually diagnosed.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2025, July 31). Small Cell Mesothelioma. Asbestos.com. Retrieved December 9, 2025, from https://www.asbestos.com/mesothelioma/small-cell/
Selby, Karen. "Small Cell Mesothelioma." Asbestos.com, 31 Jul 2025, https://www.asbestos.com/mesothelioma/small-cell/.
Selby, Karen. "Small Cell Mesothelioma." Asbestos.com. Last modified July 31, 2025. https://www.asbestos.com/mesothelioma/small-cell/.
Dr. Rupesh Kotecha is a renowned radiation oncologist in leadership roles at Miami Cancer Institute. He is an associate professor at Florida International University's college of medicine and an adjunct faculty member at Memorial Sloan Kettering.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.